Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia

被引：0
|
作者：
Jie Sun [1 ]
Juan Hu [1 ]
Yan Huang [1 ]
Shuang-Wei Ying [1 ]
Xiao-Yan Han [1 ]
Yan-Long Zheng [1 ]
He Huang [1 ]
机构：
[1] Bone Marrow Transplantation Centre,The First Affiliated Hospital of Zhejiang University
来源：
中华医学杂志英文版 | 2016年 / 129卷 / 20期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R581.4 [甲状腺炎]; R733.7 [白血病];
学科分类号：
1002 ; 100201 ; 100214 ;
摘要：
To the Editor:Sorafenib is a novel,orally available inhibitor of multiple kinases.It has been used in relapsed and refractory FMS-like tyrosine kinase（FLT） -3-positive acute myeloid leukemia（AML） in recent years with favorable outcomes.Thyroiditis and hypothyroidism as side effects have been reported in treatment on renal cell cancer.;Here,we report a case of FLT3-internal tandem duplication（ITD） -positive AML,who developed subacute thyroiditis during treatment with sorafenib.
引用
收藏
页码：2512 / 2513
页数：2
相关论文
共 50 条
  • [31] Synergistic Cytotoxicity of Sorafenib with Busulfan and Nucleoside Analogs in Human FMS-like Tyrosine Kinase 3 Internal Tandem Duplications-Positive Acute Myeloid Leukemia Cells
    Song, Guiyun
    Valdez, Benigno C.
    Li, Yang
    Liu, Yan
    Champlin, Richard E.
    Andersson, Borje S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1687 - 1695
  • [32] ITDprofiler: Computational Framework for Accurate Characterization of Structural Variants of Fms-like Tyrosine Kinase (FLT3) Internal Tandem Duplication (ITD) in Acute Myeloid Leukemia
    Faryabi, R.
    Schwartz, G. W.
    Zhou, Y.
    Lehman, A. W.
    Morrissette, J. J.
    Elenitoba-Johnson, K. S.
    Carroll, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 961 - 961
  • [33] QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML)
    Erba, Harry P.
    Patkowska, Elzbieta
    Cortes, Jorge
    Perl, Alexander E.
    Sekeres, Mikkael A.
    Dombret, Herve
    Amadori, Sergio
    Wang, Jianxiang
    Levis, Mark J.
    Schlenk, Richard F.
    Liu, Li
    Kamel, Yasser Mostafa
    Imadalou, Karima
    Laadem, Abderrahmane
    Lesegretain, Arnaud
    Montesinos, Pau
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S299 - S299
  • [34] Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Andreeff, Michael
    Cortes, Jorge
    Ravandi, Farhad
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (07) : 943 - 954
  • [35] Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity
    Yi, Hai
    Zeng, Dongfeng
    Shen, Zhaohua
    Liao, Jun
    Wang, Xiaoguo
    Liu, Yao
    Zhang, Xi
    Kong, Peiyan
    ONCOTARGET, 2016, 7 (26) : 40387 - 40397
  • [36] Targeting DNA Damage and Repair in Acute Myeloid Leukemia Carrying Internal Tandem Duplication of Fms-like Tyrosine Kinase 3 (FLT3-ITD) - a Mechanistic Study
    Nelson, Ka Lam
    Lynn, Claire
    Leung, Thomas Wing Yan
    So, Eric Chi Wai
    Leung, Anskar Yu Hung
    BLOOD, 2019, 134
  • [37] Prognostic Impact of Mutant Allele Ratio, Not Conferred by Duplicated Fragment Length, of FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia
    Cho, Y.
    Jang, S.
    Seo, E.
    Lee, J.
    Lee, J.
    Lee, K.
    Park, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 953 - 954
  • [38] Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity
    Hai, H.
    Dongfeng, Z.
    Shen, Z.
    Liao, J.
    Wang, X.
    Liu, Y.
    Zhang, X.
    Kong, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S480 - S480
  • [39] Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia
    Nazha, Aziz
    Cortes, Jorge
    Faderl, Stefan
    Pierce, Sherry
    Daver, Naval
    Kadia, Tapan
    Borthakur, Gautam
    Luthra, Raja
    Kantarjian, Hagop
    Ravandi, Farhad
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08): : 1242 - 1245
  • [40] Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation
    Shi, Jimin
    Cao, Liqin
    Luo, Yi
    Zhao, Yanmin
    Tan, Yamin
    Yu, Jian
    Lai, Xiaoyu
    Zhu, Yuanyuan
    Hu, Yongxian
    He, Jingsong
    Sun, Jie
    Zheng, Weiyan
    Wei, Guoqing
    Huang, He
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 293 - 296
12345